In May 2023, Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) and VectivBio Holding AG (Nasdaq: VECT) announced that they had entered into an agreement for Ironwood Pharmaceuticals to launch an all-cash public tender offer to acquire all outstanding shares in VectivBio Holding AG for USD 17.00 per share. The offer was successfully completed on 29 June 2023.